Pancreatic Cancer Research

ResearcherGeorgetown UniversityNo recent work listed

Marion L. Hartley

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5516-297X; OpenAlex author ID A5018018065. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers

Papers 4

  1. A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and be… Co-author DOI 10.1002/cam4.4768↗
  2. The Role of Immunotherapy in Pancreatic Cancer. Co-author DOI 10.3390/curroncol29100541↗
  3. A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1089/pancan.2019.0003↗
  4. Pancreatic cancer, treatment options, and GI-4000. Co-author DOI 10.1080/21645515.2014.1004017↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marcus Smith Noel · 2 shared papers, 2022 · strength 0.37
  2. Reetu Mukherji · 1 shared paper, 2022 · strength 0.22
  3. John Lindsay Marshall · 2 shared papers, 2014–2019 · strength 0.14
  4. Dae Won Kim · 1 shared paper, 2022 · strength 0.14
  5. Allyson J. Ocean · 1 shared paper, 2022 · strength 0.14
  6. Vincent M. Chung · 1 shared paper, 2022 · strength 0.14
  7. Andrea Wang‐Gillam · 1 shared paper, 2022 · strength 0.14
  8. Vincent J. Picozzi · 1 shared paper, 2022 · strength 0.14
  9. Philip A. Philip · 1 shared paper, 2022 · strength 0.14
  10. Aiwu Ruth He · 1 shared paper, 2019 · strength 0.09
  11. Anteneh A. Tesfaye · 1 shared paper, 2019 · strength 0.09
  12. Jonathan Robert Brody · 1 shared paper, 2019 · strength 0.09
  13. Louis M. Weiner · 1 shared paper, 2019 · strength 0.09
  14. Michael Jon Pishvaian · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.